These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21504569)

  • 21. Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction.
    Anagnostis A; Neofytou E; Soulitzis N; Kampas D; Drositis I; Dermitzaki D; Tzanakis N; Schiza S; Siafakas NM; Tzortzaki EG
    Eur J Clin Invest; 2013 Dec; 43(12):1299-306. PubMed ID: 24147598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM; Sun TY; Lin JB; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
    Xu L; Cai BQ; Zhu YJ
    Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.
    Ishikawa N; Mazur W; Toljamo T; Vuopala K; Rönty M; Horimasu Y; Kohno N; Kinnula VL
    BMC Pulm Med; 2011 May; 11():22. PubMed ID: 21569324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.
    Yu WC; Cong JP; Mi LY
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):361-367. PubMed ID: 30133616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
    Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
    BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
    Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant protein A expression and distribution in human lung samples from smokers with or without chronic obstructive pulmonary disease in China.
    Liu Z; Chen S; Xu Y; Liu X; Xiong P; Fu Y
    Medicine (Baltimore); 2020 Feb; 99(7):e19118. PubMed ID: 32049827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma surfactant Protein-D levels in healthy subjects and COPD patients.
    Khan RA; Waseem HM; Ahmad HU; Lone KP
    J Pak Med Assoc; 2019 Apr; 69(4):494-498. PubMed ID: 31000851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.
    Montaño M; Sansores RH; Becerril C; Cisneros J; González-Avila G; Sommer B; Ochoa L; Herrera I; Ramírez-Venegas A; Ramos C
    Respir Res; 2014 Jun; 15(1):74. PubMed ID: 24980707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases -8 and -9 in the Airways, Blood and Urine During Exacerbations of COPD.
    Cane JL; Mallia-Millanes B; Forrester DL; Knox AJ; Bolton CE; Johnson SR
    COPD; 2016; 13(1):26-34. PubMed ID: 26418236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
    Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
    Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Surfactant Protein-A Levels In Healthy Subjects And Chronic Obstructive Pulmonary Disease Patients.
    Waseem HM; Khan RA; Lone KP
    J Ayub Med Coll Abbottabad; 2020; 32(1):3-8. PubMed ID: 32468745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model.
    Sun J; Bao J; Shi Y; Zhang B; Yuan L; Li J; Zhang L; Sun M; Zhang L; Sun W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():717-724. PubMed ID: 28260878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
    Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
    Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of lung mitochondrial prohibitin in COPD.
    Soulitzis N; Neofytou E; Psarrou M; Anagnostis A; Tavernarakis N; Siafakas N; Tzortzaki EG
    Respir Med; 2012 Jul; 106(7):954-61. PubMed ID: 22521224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
    Xin XF; Zhao M; Li ZL; Song Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A2M Serves as Promising Biomarker for Chronic Obstructive Pulmonary Disease.
    Xiao X; Cai W; Ding Z; Shi Y; Fan L; Zhang Q
    Int J Chron Obstruct Pulmon Dis; 2023; 18():683-692. PubMed ID: 37123074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.